Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Satsuma Pharmaceuticals (STSA)

Satsuma Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STSA
DateTimeSourceHeadlineSymbolCompany
20/06/202318:03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:STSASatsuma Pharmaceuticals Inc
15/06/202313:00GlobeNewswire Inc.Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific MeetingNASDAQ:STSASatsuma Pharmaceuticals Inc
12/06/202322:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
09/06/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STSASatsuma Pharmaceuticals Inc
09/06/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:18Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:17Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:15Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:12Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
31/05/202311:04Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
31/05/202311:03Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
26/05/202311:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
25/05/202311:04Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:STSA